Operating cash flow swung from -$212M-equivalent net income in 2026Q1 with OCF of $15.9M to $946.0M in 2026Q3, while buybacks of $314.7M in the latest quarter indicate float generation is uneven and not yet a reliable base for compounding.
Markel Corporation (MKL) cash flow statement — 30-year operating, investing & financing cash flows
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 | Dec'97 | Dec'96 |
|---|
| Cash from Operations | 2.05B | 2.76B | 2.59B | 2.79B | 2.71B | 2.27B | 1.74B | 1.27B | 892.86M | 858.53M | 534.62M | 651.15M | 716.79M | 745.52M | 392.53M | 311.32M | 223.29M | 282.46M | 390.16M | 508.32M | 511.59M | 551.25M | 690.69M | 631.45M | 507.37M | 164.47M | 89.21M | 558K | 39.9M | 68.6M | 94.4M |
| Operating CF Growth % | -99.04% | 6.45% | -6.92% | 2.86% | 19.15% | 30.88% | 36.38% | 42.7% | 4% | 60.59% | -17.9% | -9.16% | -3.85% | 89.93% | 26.09% | 39.42% | -20.95% | -27.6% | -23.25% | -0.64% | -7.19% | -20.19% | 9.38% | 24.46% | 208.49% | 84.35% | 15887.99% | -98.6% | -41.84% | -27.33% | -44.14% |
| Operating CF / Revenue % | 11.99% | 16.64% | 15.49% | 17.74% | 22.94% | 17.6% | 18.03% | 13.38% | 12.85% | 14.16% | 9.53% | 12.13% | 13.96% | 17.25% | 13.08% | 11.84% | 10.03% | 13.65% | 19.74% | 20.47% | 20.31% | 25.06% | 30.53% | 30.19% | 28.66% | 11.77% | 8.15% | 0.11% | 9.37% | 16.37% | 25.74% |
| Net Income | 1.79B | 2.15B | 2.85B | 2.1B | -101.2M | 2.45B | 831.77M | 1.8B | -130.35M | 400.76M | 460.44M | 589.14M | 323.69M | 283.85M | 258.25M | 148.49M | 267.73M | 202.42M | -58.77M | 405.67M | 392.5M | 147.91M | 165.41M | 123.48M | 75.32M | -125.72M | -27.59M | 40.61M | 57.3M | 50.4M | 46.7M |
| Depreciation & Amortization | 129.6M | 347.92M | 342.36M | 319.73M | 309.45M | 336.39M | 307.07M | 269.24M | 227.85M | 203.87M | 194.15M | 200.99M | 203.58M | 190.07M | 87.33M | 70.57M | 53.59M | 31.17M | 28.67M | 30.53M | 27.61M | 29.58M | 31.34M | 39.26M | 28.23M | 41.91M | 32.4M | 12.86M | 7.3M | 7.3M | 10.9M |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11.9M | 14.3M | 16.3M | 18.7M | 18.4M | 4.4M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | 0 | 151.22M | 394.56M | 233.8M | -281.75M | 453.41M | -2.73M | 323.38M | 2.73M | -324.09M | 63.36M | -9.68M | 84.54M | 4.05M | 37.65M | 5.65M | 7.18M | -9.14M | -100.42M | 31.93M | 30.56M | -44.51M | -29.8M | -13.22M | -3.47M | -76.2M | -18.1M | 9.48M | 7M | -600K | -15.3M |
| Other Non-Cash Items | 95.33M | -850.56M | -2.06B | -1.47B | 1.58B | -1.88B | -494.68M | -1.55B | -25.17M | 20.85M | 43.46M | 67.41M | -13.83M | 13.98M | -21.93M | 26.16M | -36.36M | 96.1M | 407.59M | 31.38M | -220.02M | -37.33M | -59.16M | -143.16M | -1.18M | 311.37M | 106.99M | -68.2M | -26.8M | -22.5M | -29.3M |
| Working Capital Changes | 0 | 960.27M | 1.07B | 1.61B | 1.2B | 919.73M | 1.1B | 433.62M | 287.61M | 551.84M | -161.64M | -90.23M | 164.81M | 316.74M | 62.83M | 96.31M | -68.85M | -38.08M | 113.08M | 68.31M | 280.94M | 455.6M | 582.91M | 625.09M | 408.46M | 13.1M | -4.48M | 5.81M | -4.9M | 34M | 81.4M |
| Cash from Investing | -1.59B | -1.19B | -2.4B | -2.7B | -1.67B | -2.94B | -511.75M | -535.16M | -797.24M | -744.46M | -1.55B | 125.77M | -622.21M | 187.39M | -339.49M | -474.31M | -283.34M | -333.71M | -150.2M | -377.52M | -348.78M | -567.28M | -767.7M | -819.55M | -462.24M | -328.49M | -201.61M | -14.52M | -40.2M | -201.1M | -108M |
| Capital Expenditures | -251.25M | -206.89M | -254.99M | -258.62M | -254.71M | -145.25M | -101.3M | -123.38M | -106.59M | -74.65M | -63.67M | -79.75M | -82.13M | -47.73M | -45.52M | -60.13M | -42.1M | -21.91M | -17.67M | -14.49M | -9.19M | -29.5M | -6.96M | -7.91M | -14.55M | -8.51M | -19.63M | -4.03M | -2.7M | -4.6M | -4M |
| Acquisitions | -80.05M | -106.21M | -207.75M | -155M | 752.33M | -525.64M | -554.13M | -503M | -1.18B | -1.44B | -7.31M | -260.21M | -227.88M | 263.34M | -284.32M | -120.1M | -214.16M | -154.92M | -16.78M | -8.1M | 0 | 43.24M | 0 | 0 | 0 | 0 | -195.56M | -129.96M | 0 | 0 | 0 |
| Purchase of Investments | -3.57B | -4.27B | -4.37B | -4.94B | -3.4B | -3.42B | -2.15B | -1.05B | -444.28M | -941.54M | -2.9B | -1.64B | -3.28B | -2.12B | -854.73M | -930.07M | -957.19M | -726.95M | -1.17B | -1.65B | -2.13B | -2.44B | -3.5B | -5.24B | -2.76B | -1.38B | -891.64M | -995.45M | -574.8M | -904M | -591M |
| Sale/Maturity of Investments | 3.04B | 3.26B | 2.4B | 2.63B | 1.39B | 1.14B | 2.22B | 1.13B | 971.01M | 1.71B | 1.33B | 2.04B | 2.71B | 2.36B | 847.25M | 631.55M | 927.05M | 542.13M | 1.09B | 1.3B | 2.23B | 2.32B | 3.46B | 5.22B | 2.75B | 1.4B | 910.32M | 1.12B | 533.1M | 691.9M | 522.3M |
| Other Investing | -735.4M | 133.56M | 32.17M | 23.08M | -161.09M | 16.21M | 72.93M | 16.8M | -42.16M | 5.57M | 92.02M | 61.53M | 262.33M | -261.91M | -2.16M | 4.45M | 3.06M | 27.94M | -34.19M | -4.71M | -448.63M | -454.19M | -721.03M | -797.45M | -444.66M | -335.9M | -5.1M | -6.8M | 4.2M | 15.6M | -35.3M |
| Cash from Financing | -860.56M | -1.21B | -297.88M | -999.72M | -595.31M | 369.77M | 434.56M | 359.32M | -178.99M | 256.31M | 152.02M | -74.21M | -67.12M | 175.37M | 141.96M | 194.59M | -45.61M | 251.61M | -53.65M | -208.25M | 58.55M | -29.16M | 83.43M | 116.38M | 102.33M | 210.49M | 233.66M | 14.24M | 500K | 122.8M | 6.4M |
| Dividends Paid | -600M | -618M | -36M | -36M | -36M | -36M | -18.4M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | -170.82M | -429.52M | -572.73M | -445.48M | -290.8M | -206.52M | -26.83M | -116.31M | -54.01M | -110.84M | -51.14M | -31.49M | -26.05M | -57.39M | -16.87M | -42.91M | -45.22M | 0 | -60.6M | -24.21M | -45.88M | -15.93M | -3.38M | -4K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 552K | 4.62M | 4.75M | 5.69M | 24.52M | 0 | 1.18M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 407.53M | 0 | 0 | 0 | 0 | 0 |
| Debt Issuance (Net) | 0 | -1000K | 1000K | -1000K | -1000K | 1000K | -1000K | 1000K | -1000K | 1000K | 1000K | -1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | -1000K | 1000K | -1000K | 1000K | 1000K | 1000K | -1000K | 1000K | 1000K | 0 | -1000K | 1000K |
| Other Financing | -165.77M | -133.08M | -226.61M | -193.57M | -47.56M | -99.49M | -59.29M | -65.88M | -42.73M | -37.53M | -77.78M | -24.5M | -46.83M | 7.52M | -29.31M | -9.3M | -13.27M | -441K | 4.71M | 0 | -5K | 0 | 0 | 1.11M | 163K | -201K | -8.03M | -5.47M | 500K | 144.4M | -1.5M |
| Net Change in Cash | -421.22M | 411.05M | -139.79M | -889.48M | 340.57M | -335.7M | 1.72B | 1.1B | -104.41M | 415.68M | -891.26M | 669.84M | -18.36M | 1.11B | 198.15M | 29.77M | -105.23M | 210.12M | 161.92M | -77.45M | 221.36M | -45.18M | 6.43M | -71.72M | 147.46M | 46.46M | 121.27M | 286K | 200K | -9.7M | -7.3M |
| Exchange Rate Effect | -24.74M | 49.77M | -37.3M | 27.04M | -103.36M | -41.73M | 55.9M | 5.64M | -21.05M | 45.3M | -32.79M | -32.87M | -45.82M | 6.49M | 3.14M | -1.82M | 427K | 9.75M | -24.39M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -100K |
| Cash at Beginning | 4.07B | 4.19B | 4.33B | 5.22B | 4.88B | 5.22B | 3.5B | 2.4B | 2.5B | 2.09B | 2.63B | 1.96B | 1.98B | 863.77M | 775.03M | 745.26M | 850.49M | 640.38M | 477.66M | 555.12M | 333.76M | 378.94M | 372.51M | 444.24M | 296.78M | 250.32M | 129.06M | 1.53M | 1.3M | 11.1M | 18.3M |
| Cash at End | 4.2B | 4.6B | 4.19B | 4.33B | 5.22B | 4.88B | 5.22B | 3.5B | 2.4B | 2.5B | 1.74B | 2.63B | 1.96B | 1.98B | 973.18M | 775.03M | 745.26M | 850.49M | 639.58M | 477.66M | 555.12M | 333.76M | 378.94M | 372.51M | 444.24M | 296.78M | 250.32M | 1.81M | 1.5M | 1.4M | 11M |
| Free Cash Flow | 1.8B | 2.55B | 2.34B | 2.53B | 2.45B | 2.13B | 1.64B | 1.15B | 786.26M | 783.88M | 470.95M | 571.4M | 634.66M | 697.8M | 347.01M | 251.19M | 181.19M | 260.56M | 372.48M | 493.83M | 502.4M | 521.75M | 683.73M | 623.54M | 492.81M | 155.96M | 69.58M | -3.47M | 37.2M | 64M | 90.4M |
| FCF Growth % | -24.15% | 9.21% | -7.48% | 2.99% | 15.31% | 30.1% | 42.19% | 46.36% | 0.3% | 66.45% | -17.58% | -9.97% | -9.05% | 101.09% | 38.15% | 38.63% | -30.46% | -30.05% | -24.57% | -1.71% | -3.71% | -23.69% | 9.65% | 26.53% | 216% | 124.14% | 2106.34% | -109.32% | -41.88% | -29.2% | -45.05% |
| FCF Margin % | 10.52% | 15.4% | 13.96% | 16.09% | 20.78% | 16.48% | 16.98% | 12.09% | 11.31% | 12.93% | 8.39% | 10.64% | 12.36% | 16.14% | 11.57% | 9.55% | 8.14% | 12.59% | 18.84% | 19.89% | 19.94% | 23.71% | 30.23% | 29.81% | 27.84% | 11.16% | 6.36% | -0.66% | 8.73% | 15.27% | 24.65% |
| FCF per Share | 144.75 | 200.66 | 179.36 | 188.98 | 180.76 | 154.26 | 118.37 | 82.9 | 56.47 | 55.97 | 33.45 | 40.64 | 45.15 | 55.44 | 35.55 | 25.83 | 18.52 | 26.52 | 37.95 | 49.48 | 50.43 | 52.21 | 67.83 | 62.16 | 50.05 | 18.27 | 10.06 | -0.61 | 6.6 | 11.33 | 16.07 |
Quick answers to the most common questions about buying MKL stock.
Markel Corporation (MKL) generated $2.76B in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.
Markel Corporation (MKL) generated $2.55B in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.
Markel Corporation (MKL) spent $206.9M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.
In 2025, Markel Corporation (MKL) returned $618.0M to shareholders via cash dividends and spent $429.5M on share repurchases. This shows the company's commitment to returning capital to its equity investors.
Key Metrics
Top Statement Risk
Social inflation casualty reserve pressure
Metrics are mathematically derived from official filings.
Float Generation Turns Volatile Quarterly
Based on Markel's reported quarterly cash flows, operating cash flow swung from roughly -$212M in 2026Q1 to $946M in 2026Q3, indicating that underwriting float generation is uneven and not yet a reliable base for compounding.
The quarterly pattern suggests premium collections and claims payments are timing-sensitive, with the near-zero operating cash flow in 2026Q1 aligning with the period's combined ratio above 100%. The 2026Q3 rebound may reflect lighter claims settlement timing rather than a durable step-up in underwriting cash generation. Investors should monitor whether operating cash flow stabilizes once claims payments normalize, since sustained float growth is what funds the company's acquisition and equity investment model.
Claims Outflows Outpacing Operating Cash
As reported in the quarterly figures, claims and loss payments ran between roughly $1.2B and $2.1B per quarter over the last ten quarters, consistently absorbing a large share of premium inflows and constraining net cash retention.
Paid losses in the reported window frequently approached or exceeded operating cash flow, which suggests that the float is being consumed by claims settlement rather than accumulating. This is consistent with the social inflation pressure noted in prior statement analysis, where casualty claims may be taking longer and costing more to resolve. Whether reserves are adequate remains a question that the cash data alone cannot resolve, so the claims payment trajectory warrants further investigation.
Net Investment Deployment Remains Positive
Based on Markel's reported investment activity, purchases of investments exceeded sales and maturities in most of the last ten quarters, with net deployment ranging from roughly $0.1B to $0.7B per quarter, indicating continued capital placement rather than liquidation.
Persistent net purchases suggest management is putting available float to work in fixed income and equity holdings rather than holding excess liquidity. This supports the investment-income engine but also means portfolio cash flows are not a source of near-term liquidity. The reported figures do not indicate the realized yield on these purchases, so the return implied by the deployment cannot be confirmed from the data provided.
Buybacks Dominate Capital Returns
As reported in cash flow statements, Markel's share repurchases totaled roughly $0.07B to $0.7B per quarter in most periods, while dividends were minimal at $18M in several quarters, indicating buybacks are the primary capital return channel.
The reliance on buybacks over dividends suggests management is prioritizing capital flexibility and per-share value accretion. However, buyback pace in quarters with weak operating cash flow, such as 2026Q1 and 2026Q2, invites scrutiny of whether repurchases are funded from sustainable operating cash or from portfolio liquidation. Investors should monitor whether buybacks continue when operating cash flow stays near zero.
Net Income Diverges From Cash Reality
Based on Markel's reported figures, net income ranged from -$212M to $1.2B across the last ten quarters while operating cash flow followed a different path, with the OCF-to-net-income ratio swinging from -0.07 to 3.65, indicating that headline earnings are not a reliable proxy for cash generation.
The wide divergence between net income and operating cash flow is consistent with equity mark-to-market volatility and reserve-driven accruals flowing through earnings without corresponding cash movement. Quarters where OCF materially exceeds net income may reflect working capital timing or non-cash charges, while the reverse may reflect accrual build. Based on reported figures, the cash conversion ratio should be treated as a diagnostic rather than a quality signal in isolation.
What the Cash Statement Obscures
As reported in the quarterly data, the strongest quarters for operating cash flow coincided with heavy claims outflows, suggesting that favorable cash prints may reflect payment timing rather than sustained underwriting strength.
Quarters such as 2026Q3 and 2025Q3 show operating cash flow well above net income while claims payments remained above $1.2B, which may indicate that reserve settlements or receivable collections are flattering the period. If casualty reserve development turns adverse, the cash generation that appears robust today could reverse as deferred claims payments catch up. Investors should monitor reserve development disclosures alongside cash flow rather than treating the operating cash line as confirmation of underlying profitability.